Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Hashimoto

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
ESC Heart Failure|May 9, 2022
Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailtyYuta Nagatomi, Tomomi Ide, Tae Higuchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 1, 2026
Prognostic Value of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio for Cardiovascular Events in Statin-Treated Type 2 Diabetes With Diabetic Retinopathy Without Prior Cardiovascular DiseaseHiroka Nakashima, Shota Ikeda, Keisuke Shinohara, et al.
Nature Cardiovascular Research|August 19, 2025
Excessive HIF-1α driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxiaMasatsugu Watanabe, Masataka Ikeda, Ko Abe, et al.
Circulation|July 22, 2018
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 InhibitionToru Hashimoto, Grace E Kim, Richard S Tunin, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 3, 2025
Goreisan attenuates cardiac hypertrophy and diastolic dysfunction in heart failure with preserved ejection fraction induced by HFD/L-NAME via regulation of ICAT-β-catenin/ERK axisYoko Shojima Isayama, Shouji Matsushima, Keisuke Shinohara, et al.
Journal of the American Heart Association|March 20, 2026
Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter RegistryTaijyu Satoh, Koichiro Sugimura, Yoshihiro Fukumoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 6, 2024
Overview of the 87<sup>th</sup> Annual Scientific Meeting of the Japanese Circulation Society (JCS2023) - New Challenge With Next GenerationTetsuya Matoba, Yasuhiro Nakano, Shunsuke Katsuki, et al.
JACC. Asia|April 25, 2026
Patient Characteristics and Diagnosis of Transthyretin Amyloid Cardiomyopathy in Japan: Baseline Analysis of J-COSSAJin Endo, Kazumasa Tanzawa, Yasunori Sato, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 24, 2024
CORRIGENDUM: JCS/JSCVS/JCC/CVIT 2023 Guideline Focused Update on Indication and Operation of PCPS/ECMO/IMPELLATakashi Nishimura, Yasutaka Hirata, Takayuki Ise, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2024
JCS/JSCVS/JCC/CVIT 2023 Guideline Focused Update on Indication and Operation of PCPS/ECMO/IMPELLATakashi Nishimura, Yasutaka Hirata, Takayuki Ise, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
ESC Heart Failure|May 9, 2022
Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailtyYuta Nagatomi, Tomomi Ide, Tae Higuchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 1, 2026
Prognostic Value of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio for Cardiovascular Events in Statin-Treated Type 2 Diabetes With Diabetic Retinopathy Without Prior Cardiovascular DiseaseHiroka Nakashima, Shota Ikeda, Keisuke Shinohara, et al.
Nature Cardiovascular Research|August 19, 2025
Excessive HIF-1α driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxiaMasatsugu Watanabe, Masataka Ikeda, Ko Abe, et al.
Circulation|July 22, 2018
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 InhibitionToru Hashimoto, Grace E Kim, Richard S Tunin, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 3, 2025
Goreisan attenuates cardiac hypertrophy and diastolic dysfunction in heart failure with preserved ejection fraction induced by HFD/L-NAME via regulation of ICAT-β-catenin/ERK axisYoko Shojima Isayama, Shouji Matsushima, Keisuke Shinohara, et al.
Journal of the American Heart Association|March 20, 2026
Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter RegistryTaijyu Satoh, Koichiro Sugimura, Yoshihiro Fukumoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 6, 2024
Overview of the 87<sup>th</sup> Annual Scientific Meeting of the Japanese Circulation Society (JCS2023) - New Challenge With Next GenerationTetsuya Matoba, Yasuhiro Nakano, Shunsuke Katsuki, et al.
JACC. Asia|April 25, 2026
Patient Characteristics and Diagnosis of Transthyretin Amyloid Cardiomyopathy in Japan: Baseline Analysis of J-COSSAJin Endo, Kazumasa Tanzawa, Yasunori Sato, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 24, 2024
CORRIGENDUM: JCS/JSCVS/JCC/CVIT 2023 Guideline Focused Update on Indication and Operation of PCPS/ECMO/IMPELLATakashi Nishimura, Yasutaka Hirata, Takayuki Ise, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2024
JCS/JSCVS/JCC/CVIT 2023 Guideline Focused Update on Indication and Operation of PCPS/ECMO/IMPELLATakashi Nishimura, Yasutaka Hirata, Takayuki Ise, et al.
Pageof 15